U.S. Minor Cannabinoids Market Size, Share & Trends Report

U.S. Minor Cannabinoids Market Size, Share & Trends Analysis Report By Product (Cannabigerol (CBG), Tetrahydrocannabivarin (THCV), Cannabichromene (CBC)), By Application (Cancer, Inflammation, Neurological Disorders), And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68039-683-5
  • Number of Pages: 80
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product Type
                        1.2.2. Application
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product type outlook
                        2.2.2. Application outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Minor Cannabinoids Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. U.S. Minor Cannabinoids Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Minor Cannabinoids Market: Product Type Estimates & Trend Analysis
                    4.1. Product Type Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. U.S. Minor Cannabinoids Market by Product Type Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.4.1. Cannabigerol (CBG)
                            4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.2. Cannabichromene (CBC)
                            4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.3. Cannabinol (CBN)
                            4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.4. Tetrahydrocannabivarin (THCV)
                            4.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.5. Cannabigerolic acid (CBGA)
                            4.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.6. Others
                            4.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. U.S. Minor Cannabinoids Market: Application Estimates & Trend Analysis
                    5.1. Application Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global U.S. Minor Cannabinoids Market by Application Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.4.1. Inflammation
                            5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        5.4.2. Pain Management
                            5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        5.4.3. Neurological Disorders
                            5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        5.4.4. Cancer
                            5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        5.4.5. Others
                            5.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company/Competition Categorization
                    6.3. Vendor Landscape
                        6.3.1. Mile High Labs
                            6.3.1.1. Company overview
                            6.3.1.2. Financial performance
                            6.3.1.3. Product benchmarking
                            6.3.1.4. Strategic initiatives
                        6.3.2. GCM Holdings, LLC
                            6.3.2.1. Company overview
                            6.3.2.2. Financial performance
                            6.3.2.3. Product benchmarking
                            6.3.2.4. Strategic initiatives
                        6.3.3. GenCanna.
                            6.3.3.1. Company overview
                            6.3.3.2. Financial performance
                            6.3.3.3. Product benchmarking
                            6.3.3.4. Strategic initiatives
                        6.3.4. CBD. INC.
                            6.3.4.1. Company overview
                            6.3.4.2. Financial performance
                            6.3.4.3. Product benchmarking
                            6.3.4.4. Strategic initiatives
                        6.3.5. Rhizo Sciences
                            6.3.5.1. Company overview
                            6.3.5.2. Financial performance
                            6.3.5.3. Product benchmarking
                            6.3.5.4. Strategic initiatives
                        6.3.6. Laurelcrest
                            6.3.6.1. Company overview
                            6.3.6.2. Financial performance
                            6.3.6.3. Product benchmarking
                            6.3.6.4. Strategic initiatives
                        6.3.7. Fresh Bros Hemp Company
                            6.3.7.1. Company overview
                            6.3.7.2. Financial performance
                            6.3.7.3. Product benchmarking
                            6.3.7.4. Strategic initiatives
                        6.3.8. BulKanna
                            6.3.8.1. Company overview
                            6.3.8.2. Financial performance
                            6.3.8.3. Product benchmarking
                            6.3.8.4. Strategic initiatives
                        6.3.9. High Purity Natural Products
                            6.3.9.1. Company overview
                            6.3.9.2. Financial performance
                            6.3.9.3. Product benchmarking
                            6.3.9.4. Strategic initiatives
                        6.3.10. ZERO POINT EXTRACTION, LLC
                            6.3.10.1. Company overview
                            6.3.10.2. Financial performance
                            6.3.10.3. Product benchmarking
                            6.3.10.4. Strategic initiatives


List of Tables

Table 1 List of abbreviations
Table 2 U.S. minor cannabinoids market, by product type, 2018 - 2030 (USD Million)
Table 3 U.S. minor cannabinoids market, by application, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. minor cannabinoids market: market outlook
Fig. 9 U.S. minor cannabinoids competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 U.S. minor cannabinoids market driver impact
Fig. 15 U.S. minor cannabinoids market restraint impact
Fig. 16 U.S. minor cannabinoids market strategic initiatives analysis
Fig. 17 U.S. minor cannabinoids market: Product type movement analysis
Fig. 18 U.S. minor cannabinoids market: Product type outlook and key takeaways
Fig. 19 Cannabigerol (CBG)market estimates and forecast, 2018 - 2030
Fig. 20 Cannabichromene (CBC) market estimates and forecast, 2018 - 2030
Fig. 21 Cannabinol (CBN) market estimates market and forecast, 2018 - 2030
Fig. 22 Tetrahydrocannabivarin (THCV) market estimates and forecast, 2018 - 2030
Fig. 23 Cannabigerolic acid (CBGA) market estimates and forecast, 2018 - 2030
Fig. 24 Others (Cannabidiolic Acid (CBDA), Cannabidivarin (CBDV), And Other Minor Cannabinoids) estimates and forecast, 2018 - 2030
Fig. 25 U.S. minor cannabinoids market: Application movement Analysis
Fig. 26 U.S. minor cannabinoids market: Application outlook and key takeaways
Fig. 27 Inflammation market estimates and forecasts, 2018 - 2030
Fig. 28 Pain management market estimates and forecasts,2018 - 2030
Fig. 29 Neurological disorders market estimates and forecasts,2018 - 2030
Fig. 30 Cancer market estimates and forecasts, 2018 - 2030
Fig. 31 Others market estimates and forecasts,2018 - 2030

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon